Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-09-30

Clinical Trial Update: Non Alcoholic Fatty Liver Disease Influence of Statin Therapy [NA]

View source ↗

Summary

A clinical trial investigating the influence of statin therapy on non-alcoholic fatty liver disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Statin therapy (statin)

Snippet

Sponsor: Shaare Zedek Medical Center | Conditions: Non-alcoholic Fatty Liver Disease (NAFLD) | NA | Status: WITHDRAWN